Then, IHC was performed on neuroblastoma, SCLC, and NSCLC tumour xenografts and demonstrated enhanced expression of ACAA2 in neuroblastoma and SCLC relative to NSCLC (Fig. 4c). Here, ACAA2 is linked to neuroblastoma.